Expression of mitochondrial branched-chain aminotransferase and α-keto-acid dehydrogenase in rat brain: implications for neurotransmitter metabolism
Authors:
Open Access
- 1 January 2012
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroanatomy
- Vol. 6, 24838
Abstract
In the brain, metabolism of the essential branched chain amino acids (BCAAs) leucine, isoleucine and valine, is regulated in part by protein synthesis requirements. Excess BCAAs are catabolized or excreted. The first step in BCAA catabolism is catalyzed by the branched chain aminotransferase (BCAT) isozymes, mitochondrial BCATm and cytosolic BCATc. A product of this reaction, glutamate, is the major excitatory neurotransmitter and precursor of the major inhibitory neurotransmitter -aminobutyric acid (GABA). The BCATs are thought to participate in an α-keto-acid nitrogen shuttle that provides nitrogen for synthesis of glutamate from -ketoglutarate. The branched-chain α-keto acid dehydrogenase enzyme complex (BCKDC) catalyzes the second and first irreversible step in BCAA metabolism, which is oxidative decarboxylation of the branched-chain α-keto acid (BCKA) products of the BCAT reaction. Maple Syrup Urine Disease (MSUD) results from genetic defects in BCKDC, which leads to accumulation of toxic levels of BCAAs and BCKAs that result in brain swelling. Immunolocalization of BCATm and BCKDC in rats revealed that BCATm is present in astrocytes in white matter and in neuropil, while BCKDC is expressed only in neurons. BCATm appears uniformly distributed in astrocyte cell bodies throughout the brain. The segregation of BCATm to astrocytes and BCKDC to neurons provides further support for the existence of a BCAA-dependent glial-neuronal nitrogen shuttle since the data show that BCKAs produced by glial BCATm must be exported to neurons. Additionally, the neuronal localization of BCKDC suggests that MSUD is a neuronal defect involving insufficient oxidation of BCKAs, with secondary effects extending beyond the neuron.Keywords
This publication has 41 references indexed in Scilit:
- Dietary branched chain amino acids ameliorate injury-induced cognitive impairmentProceedings of the National Academy of Sciences, 2009
- Mediobasal Hypothalamic Leucine Sensing Regulates Food Intake through Activation of a Hypothalamus-Brainstem CircuitJournal of Neuroscience, 2009
- Branched-Chain Amino Acids May Improve Recovery From a Vegetative or Minimally Conscious State in Patients With Traumatic Brain Injury: A Pilot StudyArchives of Physical Medicine and Rehabilitation, 2008
- Hypothalamic mTOR Signaling Regulates Food IntakeScience, 2006
- Branched-Chain Amino Acids Enhance the Cognitive Recovery of Patients With Severe Traumatic Brain InjuryArchives of Physical Medicine and Rehabilitation, 2005
- Distribution of Key Enzymes of Branched-chain Amino Acid Metabolism in Glial and Neuronal Cells in CultureJournal of Histochemistry & Cytochemistry, 2001
- Role of Pyruvate Carboxylase in Facilitation of Synthesis of Glutamate and Glutamine in Cultured AstrocytesJournal of Neurochemistry, 1997
- Cellular Distribution of Branched-chain Amino Acid Aminotransferase Isoenzymes Among Rat Brain Glial Cells in CultureJournal of Histochemistry & Cytochemistry, 1997
- Generation of Ketone Bodies from Leucine by Cultured Astroglial CellsJournal of Neurochemistry, 1995
- Biochemistry and physiology of brain ammonia.Physiological Reviews, 1987